1. Hypoxia-responsive PPARGC1A/BAMBI/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma
   Qiangnu Zhang et al, 2023, Oncogene CrossRef
2. EZH2 serves as a promising therapeutic target for fibrosis
   Qian Zhang et al, 2023, Bioorganic Chemistry CrossRef